bazedoxifene has been researched along with Vaginal Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, L; Bushmakin, AG; Komm, BS; Pinkerton, JV | 1 |
| Pinkerton, JV; Stanczyk, FZ | 1 |
| Komm, BS; Mirkin, S | 1 |
| Abraham, L; Komm, BS; Messig, M; Mirkin, S; Pinkerton, JV; Ryan, KA | 1 |
| Raney, EC | 1 |
| Abraham, L; Bushmakin, AG; Cappelleri, JC; Komm, BS; Pinkerton, JV | 1 |
| Crider, M; Hill, DA; Hill, SR | 1 |
| Kagan, R; Mirkin, S; Pan, K; Pickar, JH; Williams, RS | 1 |
| Bachmann, G; Bobula, J; Mirkin, S | 1 |
| Lindsay, R | 1 |
| Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J | 1 |
5 review(s) available for bazedoxifene and Vaginal Diseases
| Article | Year |
|---|---|
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
Tissue-selective estrogen complexes for postmenopausal women.
Topics: Breast; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Sleep; Uterus; Vaginal Diseases | 2013 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Collagen Type I; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Peptides; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vaginal Diseases | 2011 |
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2012 |
5 trial(s) available for bazedoxifene and Vaginal Diseases
| Article | Year |
|---|---|
Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
Topics: Adult; Aged; Atrophy; Coitus; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Pain; Postmenopause; Pruritus; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Vagina; Vaginal Diseases; Vulva | 2017 |
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
Topics: Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Middle Aged; Pain, Intractable; Surveys and Questionnaires; Treatment Outcome; Vaginal Diseases | 2016 |
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Topics: Administration, Intravaginal; Adult; Aged; Atrophy; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Postmenopause; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2010 |
Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
Topics: Administration, Intravaginal; Atrophy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Behavior; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2010 |
1 other study(ies) available for bazedoxifene and Vaginal Diseases
| Article | Year |
|---|---|
What new therapeutic options exist for the relief of menopausal symptoms?
Topics: Atrophy; Bone Density; Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Vaginal Diseases; Vulvar Diseases | 2015 |